Ban katantaProducts A-Z
Ban katantaProducts A-Z
Actemra/RoActemra (tocilizumab)
Alecensa (alectinib)
Avastin (bevacizumab)
CellCept (mycophenolate mofetil)
Copegus (ribavarin)
Cotellic (cobimetinib)
Enspryng (satralizumab)
Erivedge (vismodegib)
Esbriet (pirfenidone)
Evrysdi (risdiplam)
Fuzeon (enfuvirtide)
Gazyva/Gazyvaro (obinutuzumab)
Hemlibra (emicizumab)
Herceptin (trastuzumab)
Herceptin SC / Herceptin Hylecta (trastuzumab hyaluronidase)
Invirase (saquinavir)
Kadcyla (trastuzumab emtansine)
MabThera / Rituxan (rituximab)
MabThera SC / Rituxan Hycela (rituximab hyaluronidase)
Madopar (levodopa benserazide)
Mircera (methoxy polyethylene glycol epoetin beta)
NeoRecormon (epoetin beta)
Ocrevus (ocrelizumab)
Pegasys (peginterferon α)
Perjeta (pertuzumab)
Phesgo (pertuzumab trastuzumab hyaluronidase)
Polivy (polatuzumab vedotin)
Pulmozyme (dornase alfa)
Rivotril (clonazepam)
Roaccutane/Accutane (isotretinoin)
Rocephin (ceftriaxone)
Rozlytrek (entrectinib)
Tamiflu (oseltamivir)
Tarceva (erlotinib)
Tecentriq (atezolizumab)
Valcyte (valganciclovir)
Valium / Valrelease (diazepam)
Xeloda (capecitabine)
Xofluza (baloxavir marboxil)
Zelboraf (vemurafenib)
Ban katantaDisease areas
Disease areas
All areas
Anaemia
Cancer (blood tumours)
Cancer (solid tumours)
Dermatology
Haemophilia
Infectious Diseases
Inflammatory & Autoimmune Diseases
Neurological Disorders
Respiratory Disorders
Transplantation
Products for Researchers
Products for Researchers
Solutions for Diagnostics
Solutions for Diagnostics